MARKET

DRUG

DRUG

Bright Minds Biosciences Inc
NASDAQ
32.27
-0.34
-1.04%
Opening 15:27 05/14 EDT
OPEN
32.27
PREV CLOSE
32.61
HIGH
33.12
LOW
31.55
VOLUME
22.70K
TURNOVER
--
52 WEEK HIGH
79.02
52 WEEK LOW
0.9305
MARKET CAP
227.31M
P/E (TTM)
-191.3998
1D
5D
1M
3M
1Y
5Y
1D
Bright Minds Biosciences Reports Promising Results for Epilepsy Treatment
TipRanks · 1d ago
TD Cowen Initiates Coverage On Bright Minds Biosciences with Buy Rating
Benzinga · 1d ago
Coinbase, Caterpillar upgraded: Wall Street’s top analyst calls
TipRanks · 1d ago
Bright Minds announces findings from mouse model study of BMB-101
TipRanks · 1d ago
Bright Minds Biosciences Announces Findings From Its DBA/2 Mouse Model Study Evaluating BMB-101; Demonstrated A Complete Elimination Of Drop Attacks; Findings Highlight BMB-101's Potential To Address Critical Gaps In SUDEP Prevention
Benzinga · 1d ago
BRIGHT MINDS BIOSCIENCES INC - BMB-101 SAFE AND WELL TOLERATED IN PHASE 1 STUDIES
Reuters · 1d ago
Bright Minds initiated with a Buy at TD Cowen
TipRanks · 1d ago
Bright Minds Biosciences’ BMB-101: A Promising Anti-Seizure Drug with Billion-Dollar Market Potential
TipRanks · 1d ago
More
About DRUG
More
Bright Minds Biosciences Inc. is a biotechnology company, which is engaged in developing treatments for patients with neurological and psychiatric disorders. The Company is focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, depression, and other central nervous system (CNS) disorders. Its Serotonin (5-HT) is a neurotransmitter in the brain and modulates many biological functions. Dysfunction of serotonin receptors, transporters, and associated neurocircuits is fundamental to many diseases including epilepsies and neuro psychiatric. Its pipeline includes BMB-101, BMB-xxx, BMB-201, and BMB-202. The Company has a portfolio of patented, selective serotonin (5-HT2C, 5-HT2A and 5-HT2C/A-receptor subtypes) agonists that were identified by using high-throughput screening methods in combination with advanced molecular modeling techniques to interrogate the interaction between the drug and its targeted receptors to increase downstream signaling.
Recently
Symbol
Price
%Change

Webull offers Bright Minds Biosciences Inc stock information, including NASDAQ: DRUG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DRUG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DRUG stock methods without spending real money on the virtual paper trading platform.